{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:26:39Z","timestamp":1715588799503},"reference-count":18,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jacc.2017.07.751","type":"journal-article","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T18:15:39Z","timestamp":1503944139000},"page":"1245-1247","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["New Pharmacological Target to Treat Ischemic Mitral Regurgitation"],"prefix":"10.1016","volume":"70","author":[{"given":"Luc A.","family":"Pierard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Magne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.07.751_bib1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000151693","article-title":"Ischemic mitral regurgitation: a complex multifaceted disease","volume":"112","author":"Magne","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2017.07.751_bib2","first-page":"2451","article-title":"Guidelines on the management of valvular heart\u00a0disease (version 2012): the Joint Task Force on the\u00a0Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.07.751_bib3","first-page":"2440","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Nishimura","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.07.751_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.107.749440","article-title":"Mitral leaflet adaptation to ventricular remodeling: occurrence and adequacy in patients with functional mitral regurgitation","volume":"118","author":"Chaput","year":"2008","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.jacc.2017.07.751_bib5","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1161\/CIRCULATIONAHA.109.844019","article-title":"Mitral leaflet adaptation to ventricular remodeling: prospective changes in a model of ischemic mitral regurgitation","volume":"120","author":"Chaput","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.07.751_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ehjci\/jev314","article-title":"Elongation of chordae tendineae as an adaptive process to reduce mitral regurgitation in functional mitral regurgitation","volume":"17","author":"Obase","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2017.07.751_bib7","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jacc.2013.01.064","article-title":"Mitral valve enlargement in chronic aortic regurgitation as a compensatory mechanism to prevent functional mitral regurgitation in the dilated left ventricle","volume":"61","author":"Beaudoin","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.07.751_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jacc.2015.10.092","article-title":"Myocardial infarction alters adaptation of the tethered mitral valve","volume":"67","author":"Dal-Bianco","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.07.751_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2004.06.079","article-title":"Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study","volume":"45","author":"Grande-Allen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.07.751_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.RES.0000136520.07995.aa","article-title":"Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease","volume":"95","author":"Walker","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2017.07.751_bib11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bbrc.2014.03.014","article-title":"Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-\u03b2-induced phosphorylation of ERK","volume":"446","author":"Wylie-Sears","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacc.2017.07.751_bib12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jacc.2017.07.734","article-title":"Effect of losartan on mitral valve changes after myocardial infarction","volume":"70","author":"Bartko","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.07.751_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1312808","article-title":"Mitral-valve repair versus replacement for severe ischemic mitral regurgitation","volume":"370","author":"Acker","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.07.751_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJMoa1512913","article-title":"Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation","volume":"374","author":"Goldstein","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.07.751_bib15","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1410490","article-title":"Surgical treatment of moderate ischemic mitral regurgitation","volume":"371","author":"Smith","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.07.751_bib16","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMoa1602003","article-title":"Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation","volume":"374","author":"Michler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.07.751_bib17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on morbidity and mortality in high risk patients after acute myocardial infarction","volume":"360","author":"Dickstein","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.07.751_bib18","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717389659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717389659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:48:34Z","timestamp":1536194914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717389659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0735109717389659"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.07.751","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Pharmacological Target to Treat Ischemic Mitral Regurgitation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.07.751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.07.734","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}